Research Focus

Dr. Dhar’s team develop macromolecular technologies, which are engineered to nanoparticles and targeted to the mitochondria of cells and they have chemistry-based programs on combination therapy for various cancers. Dr. Dhar’s team also work in the areas of diagnosis and combination therapies for cancer, cardiovascular and viral diseases. Their research program includes design, synthesis, in vitro, and pre-clinical testing of different Nanomedicine platforms. As a research team with a strong background in chemistry, they aim to provide the scientific community with valuable knowledge that can guide into the discovery of potential drug candidates and vaccines.